AR-2126

N/A

Report date: 2025/04/29 17:58:42
NME

Base Information

Drug NameAR-2126
Drug Alias NameAR-2126
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHospital-acquired pneumoniaPyelonephritisBronchiectasis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesARIVA Med GmbH
China Registration ClassN/A

Develop Information

Active CompaniesARIVA Med GmbH
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaPyelonephritisBronchiectasis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A